Customized research for ARPO vs. PGNX!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ARPO vs. PGNX.


↗ Join Our Free Email Newsletter.




Aerpio Pharmaceuticals Inc. vs. Progenics Pharmaceuticals, Inc.

Industry Match! Industry of Both ARPO and PGNX:

Health Care/Life Sciences

ARPO

Key Statistics

Cap: 159.483M


P/E: N/A

P/S: 13.82

Q P/B: 2.4

Y Rev: 11.54M

Q Rev: 18.82M

Beta: N/A

ARPO Share Stats

Outstanding Shares

40.6M

Float Shares

11.08M

Percent of Float Short

0.05%

ARPO Insider Stats

Percent Outstanding Insider Ownership

1.15%

Percent Outstanding Institution Ownership

30.18%

ARPO Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ARPO in Pulse Portal

Stream of Posts

ARPO Symbol Page

Share ARPO Insights

Express Sentiment

'Buy' or 'Sell' ARPO

ARPO Profile

CEO

Mr. Muneer A. Satter

Exchange

Nasdaq

Employees

25.00

About

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its lead program include a Tie2 activator for diabetic retinopathy and hypoxia-inducible factor. The company was founded by Joseph...

ARPO Financials

Annual Financials

Income Statement

Revenue

11.54M

Net Income

292.61%

Cash Flow Statement

Change in Cash / Investments

18.65M

Balance Sheet

Cash / Investments

20.26M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

20.9M

Total Current Liabilities

3.59M

Total Assets

21.03M

Total Liabilities

3.59M

Stockholder Equity

17.44M

Quarterly Financials

Income Statement

Q Revenue

18.82M

Q Net Income

11.54M

Cash Flow Statement

Q Change in Cash / Investments

24,057

Balance Sheet

Q Cash / Investments

68.81M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

70.04M

Q Total Current Liabilities

3.64M

Q Total Assets

70.16M

Q Total Liabilities

3.64M

Q Stockholder Equity

66.52M

ARPO Charts

10-Year Chart

ARPO 10-Year Chart

5-Year Chart

ARPO 5-Year Chart

1-Year Chart

ARPO 1-Year Chart

6-Month Chart

ARPO 6-Month Chart

3-Month Chart

ARPO 3-Month Chart

1-Month Chart

ARPO 1-Month Chart

1-Day Chart

ARPO 1-Day Chart

PGNX

Key Statistics

Cap: 373.678M


P/E: N/A

P/S: 23.92

Q P/B: 3.7

Y Rev: 15.62M

Q Rev: 3.24M

Beta: 1.83

PGNX Share Stats

Outstanding Shares

84.54M

Float Shares

83.85M

Percent of Float Short

11.63%

PGNX Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

6% per year%

PGNX Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

PGNX in Pulse Portal

Stream of Posts

PGNX Symbol Page

Share PGNX Insights

Express Sentiment

'Buy' or 'Sell' PGNX

PGNX Profile

CEO

Mr. Mark Robert Baker

Exchange

Nasdaq

Employees

79.00

About

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul...

PGNX Financials

Annual Financials

Income Statement

Revenue

15.62M

Net Income

(67.66M)

Cash Flow Statement

Change in Cash / Investments

47.06M

Balance Sheet

Cash / Investments

137.69M

Short Term Debt

None

Long Term Debt

39.18M

Total Current Assets

144.13M

Total Current Liabilities

23.45M

Total Assets

169.5M

Total Liabilities

68.42M

Stockholder Equity

101.08M

Quarterly Financials

Income Statement

Q Revenue

3.24M

Q Net Income

(14.7M)

Cash Flow Statement

Q Change in Cash / Investments

(11.16M)

Balance Sheet

Q Cash / Investments

137.69M

Q Short Term Debt

None

Q Long Term Debt

39.18M

Q Total Current Assets

144.13M

Q Total Current Liabilities

23.45M

Q Total Assets

169.5M

Q Total Liabilities

68.42M

Q Stockholder Equity

101.08M

PGNX Charts

10-Year Chart

PGNX 10-Year Chart

5-Year Chart

PGNX 5-Year Chart

1-Year Chart

PGNX 1-Year Chart

6-Month Chart

PGNX 6-Month Chart

3-Month Chart

PGNX 3-Month Chart

1-Month Chart

PGNX 1-Month Chart

1-Day Chart

PGNX 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon